Neovascularization of the amniotic membrane as a biological immune barrier

Transplantation Proceedings

Volumn 36, Issue 4, 2004, Pages 1194-1198

  Mahgoub, M A ^a   Ammar, A ^a   Fayez, M ^a   Edris, A ^b   Hazem, A ^a   Akl, M ^a   Hammam, O ^a  

^a Ain Shams University Hospital   (Egypt)

^b Ain Shams University Hospitals ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; EOSIN; HEMATOXYLIN;

AMNION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; BIOCOMPATIBILITY; BLOOD VESSEL; CELL ENCAPSULATION; CELL MEMBRANE; CELL PROLIFERATION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DOG; FIBROBLAST; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICROSCOPY; NONHUMAN; OMENTUM; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PERITONEAL CAVITY; PREGNANCY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THROMBOSIS;

AMNION; ANIMALS; CAPSULES; CELL CULTURE TECHNIQUES; CELL SURVIVAL; DOGS; FEMALE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; KINETICS; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; TRANSPLANTATION, HETEROLOGOUS;

EID: 2942677281     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.04.019     Document Type: Conference Paper

References (25)

1. Scharp D.W., Mason N.S., Sparks R.E. The use of hybride artificial organs to prevent islet tissue rejection. World J Surg. 8:1984;221
2. Dionne K, Hegre O, Scharp D, et al. Macroencapsulation of islets for the treatment of diabetes. Pancreatic Islet Transplantation volume III, chapter 9. 1994; p 119
3. Mahgoub M.A., Monayeri M.E., Mohfouz M. Moghazy capsule as a Bioartificial pancreas in xenotransplantation. Transplant Proc. 24:1992;659
4. Sippel K.C., Maj J., Foster C.S. Amniotic membrane surgery. Curr Opin Ophthalmol Aug. 12:2001;269
5. Kim S.C., Kim T.H., We Y.M., et al. Study of improvement of early implantation and long term graft survival in pancreatic islet cell transplantation by induction of angiogenesis with gene transplantation of vascular endothelial growth factor. Transplant Proc. 35:2003;486
6. Tibell A., Rafael E., Wennberg L., et al. Survival of macroencapsulated allogenic parathyroid tissue one year after transplantation in nonimmunouppressed humans. Cell Transplant. 10:2001;591
7. rd Scientific Sessions of ADA 59 OR, 2003; p A14
8. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science. 210:1980;908
9. Darqur S., Reach G. Immunoisolation of pancreatic B cells by microencapsulation. An in vitro study. Diabetologia. 28:1985;776
10. Sun Y., Ma X., Zhou D., et al. Normalization of diabetes in spontaneously diabetic cynomologus monkey by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest. 98:1996;1417
11. Paradis K, Langford G, Long Z: Search for cross species transmission of porcine endogenous retrovirus in patients treated with living pig tissue science. 285:1236, 1999
12. Elliot RB, Escobar L, Garkavenko O, et al. No evidence of infection with porcine endognous retrovirus in recipients of encapsulated porcine islet cell xenografts. Cell transplant 9: 2000
13. Rafael E., Gazelius B., Wu G.S., et al. A longitudinal studies on the microcirculation around Thera Cyte immunoisolation device using laser Doppler technique. Cell Transplantation. 9:2000;107
14. Lanza R.P., Chick W.L. Transplantation of encapsulated cells and tissues. Surgery. 121:1997;1
15. Maki T., Ubhi C.S., Sanchez-Farpon H., et al. Successful treatment of diabetes with the biohybrid artificial pancreas in dogs. Transplantation. 51:1991;43
16. Loudovaris T., Jacobs S., Youg S., et al. Correction of diabetic NOD mice with insulinoma implanted within Baxter immunoisolation devices. J Mol Med. 77:1999;219
17. Zekom T., Horcher U., Siebers K., et al. Islet transplantation in immunoseparting membranes for treatment of insulin-dependent diabetes mellitus. Exp Clin Endocrinol Diabetes. 103:1995;136
18. Scharp D.W., Swanson C.J., Olack B.J., et al. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and nondiabetic control subjects. Diabetes. 43:1994;1167
19. Jesser C., Kessler L., Lambert L., et al. Pancreatic islet macroencapsulation a new device for the evaluation of artificial membrane. Artif Organs. 20:1996;997
20. Brauker J.H., Martinson L.A., Young S.K., et al. Local inflammatory response arounds diffusion chambers containing xenografts. Transplantion. 61:1996;1671
21. Scharp D.W., Marchetti P., Swanson C., et al. The effect of transplantation site and islet mass on Long-term survival and metabolic and hormonal function of canine purified islet autografts. Cell Transplantation. 1:1992;245
22. Akle C., Me Coll I., Dean M., et al. Transplantation of amniotic epithelial membranes in patients with mucopolysaccharidosis. Exp Clin Immunogenet. 2:1985;43
23. Faulk W.P., Matthews R., Stevens P.J., et al. Human amnion as an adjunct in wound healing. Lancet. 31:1980;1156
24. Burgos H. Angiogenic and growth factors in human amnion chorion and placenta. Eur J Clin Invest Aug. 13:1983;289
25. Maldonato A., Lucisano A., Maniccia E., et al. Amniotic membrane diffusion chambers a new possibility for pancreatic islet transplantation. Life Support Syst Suppl. 1:1985;640